172 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
or an employee benefit plan of that Party (including any trustee of such plan acting as trustee)) hereafter acquires beneficial ownership of securities
424B7
uedtb725npi5sth
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-99.1
44x e3m5yu
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-10.1
4ozie vyvpeh4k8fvh4
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K/A
EX-99.1
034av2un
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-10.1
02ht3c nhoyriwg2m8
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
qa26fpjwj4c zh6uh318
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
8zfz 54syqgm78
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am